[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100473731":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":33,"responsibleParty":87,"collaborators":90,"id":95,"slug":96,"hasResults":97,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":10,"eligibilityCriteria":101,"healthyVolunteers":97,"sex":102,"minAge":103,"maxAge":10,"enrollmentInfo":104,"targetDuration":10,"studyType":107,"phases":10,"briefSummary":108,"conditions":109,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Huazhong University of Science and Technology","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1",null,"Lung cancer patients treated with thoracic radiotherapy",[13],"Other: Blood Samples for Biomarkers",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Blood Samples for Biomarkers","blood sample to be taken at baseline, during radiotherapy, and after radiotherapy",[9],[20],{"name":21,"affiliation":22,"role":23},"Xianglin Yuan, PhD","Tongji Hospital","PRINCIPAL_INVESTIGATOR",[25,29],{"name":21,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","+8613667241722","yuanxianglin@hust.edu.cn",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Lingyan Xiao, MD","+8615971474885","lingyan.xiao123@gmail.com",[34,57,68],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","43000","China","CN",{"type":43,"coordinates":44},"Point",[45,46],114.26667,30.58333,{"lat":46,"lon":45},[49,53],{"name":50,"role":26,"phone":51,"phoneExt":10,"email":52},"Guang Han, PhD","+8613886048178","hg7913@hotmail.com",{"name":54,"role":26,"phone":55,"phoneExt":10,"email":56},"Ying Li, MD","+8613628635363","hbwhw08@163.com",{"facility":58,"status":36,"city":37,"state":38,"zip":59,"country":40,"countryCode":41,"cosmosGeoPoint":60,"geoPoint":62,"contacts":63},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","430030",{"type":43,"coordinates":61},[45,46],{"lat":46,"lon":45},[64,65,66],{"name":21,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},{"name":67,"role":23,"phone":10,"phoneExt":10,"email":10},"Xianglin Xianglin, PhD",{"facility":69,"status":36,"city":70,"state":71,"zip":72,"country":40,"countryCode":41,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Jingjiang People' Hospital","Jingjiang","Jiangsu","214500",{"type":43,"coordinates":74},[75,76],120.2625,32.01417,{"lat":76,"lon":75},[79,83],{"name":80,"role":26,"phone":81,"phoneExt":10,"email":82},"Dewen Wang, Bachelor","+8613815985599","jsjjwdw@163.com",{"name":84,"role":26,"phone":85,"phoneExt":10,"email":86},"Lihua Fan, MD","+8613852619599","980692748@qq.com",{"type":23,"investigatorFullName":88,"investigatorTitle":89,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Xianglin Yuan","Professor, Chief Physician",[91,93],{"name":92,"class":6},"Hubei Cancer Hospital",{"name":69,"class":94},"UNKNOWN","100473731","a-study-on-predictive-models-and-clinical-outcome-of-radiation-pneumonitis-100473731",false,"NCT05448703","A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis","A Multicenter Prospective Observational Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis","Inclusion Criteria:\n\n1. Clinical diagnosis of lung cancer by histology\n2. Radiation dose at least 45 Gy\n3. Karnofsky \\>60\n4. Age\\>18\n5. Life expectancy of at least 6 months\n\nExclusion Criteria:\n\n1. Previous thoracic irradiation\n2. Severe cardiopulmonary diseases","ALL","18 Years",{"count":105,"type":106},300,"ESTIMATED","OBSERVATIONAL","Radiation pneumonitis is the main dose-limiting toxicity of thoracic radiotherapy, which can affect life quality, survival, and the tumor-controlling effects of patients receiving thoracic radiotherapy.\n\nThe purpose of this study is to:\n\n* Identify biomarkers including serum proteins, gene expression, genetic changes, and epigenetic modifications that determine radiation pneumonitis.\n* Investigate the relationship between radiation pneumonitis and other toxicities induced by radiotherapy.\n* Construct a predictive model for radiation pneumonitis.\n* Evaluate survival and treatment outcome of patients with radiation pneumonitis.",[110],"Radiation Pneumonitis","2022-10-05",{"date":113,"type":114},"2022-10-06","ACTUAL",{"date":116,"type":114},"2021-02-25",{"date":118,"type":106},"2026-09-01",{"name":5,"class":6},3]